M&A Deal Summary

Recordati Acquires Tonipharm S.A.S.

On December 21, 2018, Recordati acquired medical products company Tonipharm S.A.S.

Acquisition Highlights
  • This is Recordati’s 5th transaction in the Medical Products sector.
  • This is Recordati’s 5th transaction in France.

M&A Deal Summary

Date 2018-12-21
Target Tonipharm S.A.S.
Sector Medical Products
Buyer(s) Recordati
Deal Type Add-on Acquisition

Target

Tonipharm S.A.S.

Boulogne-Billancourt, France
Tonipharm S.A.S. promotes a wide portfolio of self-medication products together with some prescription drugs. The company’s sales are generated mainly by the line of products sold under the umbrella brand Ginkor, OTC treatments based on ginko biloba which are very well known on the French market. The company also promotes Alodont®, a line of products used for oral hygiene.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Recordati

Milan, Italy

Category Company
Founded 1926
Sector Medical Products
Employees4,450
Revenue 2.3B EUR (2024)
DESCRIPTION

Recordati is an international pharmaceutical group dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, other Central and Eastern European countries, Turkey, North Africa, the United States of America, Canada, Mexico and in some South American countries. An efficient field force of medical representatives promotes a wide range of innovative pharmaceuticals, both proprietary and under license, in a number of therapeutic areas including a specialized business dedicated to treatments for rare diseases. Recordati was founded in 1926 and is based in Milan, Italy.


DEAL STATS #
Overall 17 of 17
Sector: Medical Products M&A 5 of 5
Type: Add-on Acquisition M&A Deals 15 of 15
Country: France M&A 5 of 5
Year: 2018 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-07-14 Pro Farma AG

Baar, Switzerland

Pro Farma AG is a pharmaceutical company. Pro Farma specialties in selected therapeutic areas which include both prescription and OTC drugs. The main brands are Lacdigest (tilactase), Tretinac (isotretinoin) and Urocit (potassium citrate).

Buy Fr.16M